記憶度
15問
35問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
No idea on the target of the compound Expensive
Random screening
2
the higher the affinity of a compound to receptor the stronger and more stable their bonding
t
3
Organic medicinal chemistry
both
4
In organic medicinal chemistry, we combine expertise from chemistry and biology to:
all
5
medicinal chemistry
both
6
basic understanding on medical principles, develop drug for diseases occurring in the community, significance in society skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
7
7
drug formulation, design appropriate formulation of drug skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
6
8
to optimize and modify the chemical structure of the drug to be more potent, enhance the effectiveness of the drug, and minimize the side effects skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
5
9
understand normal process of the body to design a drug that is more effective with lesser side effects, understand pharmacokinetic processes skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
4
10
identify potential biological targets, bind to specific enzyme skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
3
11
biochemical process of living organisms to design compounds that would specifically target receptors and enzymes associated with a particular specie skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
2
12
chemical structure, nomenclature, reaction, synthesis skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
1
13
hypertension, if you know that angiotensin enzyme is associated with an increase in bp, you can design a drug that would target the angiotensin-converting enzyme skills and knowledge needed: 1- Chemistry 2- Biochemistry 3- Molecular Biology 4- Physiology 5- Pharmacology 6- Pharmaceutics 7- Medicine
3
14
field of science that manipulates living organism, cells, to create products
biotechnology
15
Cell – stimulating factors
dosing regimen for chemotherapy body will release factors to stimulate cells to grow and divide
16
Humanized monoclonal antibodies
target specific tissues ; It is designed to target specific antigen (more selective) producing lesser side effects
17
Allows convenient production of insulin with lesser allergic reaction Inject insulin genes on microorganism (E. coli) to produce high yield of insulin
biotechnology
18
CONSIDERATIONS IN UNDERSTANDING THE PRINCEIPLES OF MEDICINAL CHEMISTRY EXCEPT:
affinity
19
It is important to consider the physicochemical properties of a drug in order to influence the absorption of the drug, distribution, metabolism, and even the pharmacologic response.
t
20
If the drug has activity on a particular enzyme, the receptor or enzyme to be targeted is known which would help determine the disease to be managed as well
moa
21
Idea on metabolic product if it may cause toxicity or easily metabolized giving an idea on duration of action Phase of metabolism and potential toxic effects and side effects of metabolites to easily optimize it e.g., easily metabolized at low pH (optimize to an enteric coating)
drug metabolism
22
Different enantiomers have different effects (Thalidomide R and S) one enantiomer has teratogenic effect which causes phocomelia while the other enantiomer has no teratogenic effect (remove 1 enantiomer to make it safer)
t
23
Spatial arrangement of atoms in a molecule
stereochemistry
24
Racemic compound is a mixture of 3 enantiomer
f
25
PHYSICOCHEMICAL PROPERTIES OF LEAD COMPOUNDS CAN PROVIDE NEW DRUGS
t
26
The first histamine 2 antagonist developed
all
27
Histamine 2 is responsible for the production of gastric acid. If the receptor is stimulated, it would produce gastric acid. Through this, they developed a compound similar to histamine 2, They modified it to antagonize or inhibit histamine 2 receptors.
t
28
Ranitidine is derived from Cimetidine which is prone to side effects and various ADRs.
t
29
Generally, medicinal chemists can except:
none
30
Medicinal chemistry is devoted to the discovery and development of new agents for treating diseases Goal is to discover new therapeutic agent regardless of if it is organic or inorganic as long as it is effective
both t
31
receptors
Substances to which a drug needs to interact with to elicit pharmacologic response
32
Receptors a relatively small region of a macromolecule which may be an/a:
all
33
_ are protein that interacts with a ligand to elicit pharmacologic response _ interacts with a substrate to catalyze a chemical reaction (speeds up the biochemical reaction)
Receptor Enzyme
34
Affinity
all
35
Intrinsic activity
all
36
Ability of a drug to exert a pharmacologic action
Intrinsic activity
37
Compound binds to receptor and stimulates the effect or receptor to produce a pharmacologic effect
Agonist
38
• Drug with affinity and intrinsic activity • Increases therapeutic response • Elicit pharmacologic response
agonist
39
• Drug with affinity but does not have intrinsic activity • Block the activity of the receptor • Does not elicit pharmacologic response
antagonist
40
The response of a compound would depend on the presence of full agonist. If full agonist is present compound will act as antagonist. If full antagonist is absent the compound will act as agonist
Agonist-antagonist
41
Morphine _ to opiod receptor
agonist
42
Naloxone _ opiod receptor
antagonist
43
Buprenorphine
agonist-antagonist
44
In the presence of a full agonist, a compound acts as an antagonist as they compete on the same receptor. If there is a presence of a full agonist, the compound will become antagonist where if it binds to the receptor, it will block the activity and would not elicit a response In the absence of full antagonist, it will act as an agonist. It will stimulate the receptor producing a therapeutic response
t
45
In the presence of antagonist, its effect is agonist, in the absence of an antagonist its effect is agonist The response of a compound is dependent on the presence of a full agonist
t
46
Pure organic compounds are the chief source of agents for the cure, mitigation, or the prevention of diseas
t
47
Derived from plants, animals, microorganisms, fungi, bacteria
natural
48
Synthetically made in the laboratory using chemicals (compounds made in lab using chemicals)
synthethic
49
Other things that would affect the pharmocologic activity of the drug are physicochemical properties, solubility, pH, pharmacokinetic properties. it is better to categorize drugs through indication such as inflammatory, analgesic, anti-hypertensive
both t
50
Drugs that act on the various physiological functions of the body (e.g., pain reliever , anti-inflammatory agents, general anesthetic, hypnotic and sedatives, analgesic etc.)
pharmacodynamic agents
51
drugs which are used to fight pathogens, bacteria, virus, cancer cells, fungi (e.g., sulfonamides, antibiotics, anti-malarial agents, antiviral, anticancer, etc.)
chemotherapeutic
52
Diseases that can be transmitted from one person to another Diseases that cannot be transmitted from person to person not caused by pathological state but rather a normal aspect of life
Infectious Non infectious Non diseases
53
Disorders of the human body caused by generic malfunction, environmental factors, stress, old age, etc.
non infectious
54
No changes in the body normal response e.g pain, contraception, drugs that are used as anesthetic agent Alleviation of pain (analgesic), prevention of pregnancy (contraception), anesthesia
non diseases
55
Infectious disease and its causative agent? Pneumonia – Salmonella – Thrush –
Streptococcus pneumoniae Typhi Candida Albicans
56
Athlete's foot
Tinea pedis
57
Malaria
Plasmodium falciparum
58
Amantadine is used Parkinsons but it was originally used in influenza. Later on, they found out that amantadine has an activity against Parkinsons disease.
t
59
Logical test Has knowledge or idea (you have prior knowledge) Systematic development based on the understanding about MOA or biological target
rational drug design
60
With enzyme linked assays or receptors from gene cloning of existing drugs lead to identification of new lead drug E.g., Amantadine
random screening
61
• X-ray crystallography • Nuclear magnetic resonance Evaluate the structure of the compound and design the compound in a way that it would interact with the target
rational drug design
62
HIV protease inhibitor
Involved in the maturation of the HIV virus
63
cimetidine
h2 antagonist
64
aliskerin
renin inhibitor
65
you are using living organisms you can optimize them or manipulate them to produce useful products. The two most commonly use are recombinant dna and mutagenesis
biotechnology techniques
66
Induce changes in the DNA sequence Induce mutation in DNA In DNA sequence, pick specific location where the mutation willhappen
mutagenesis
67
you are manipulating DNA or genetic material e.g insulin. The genes involved in the production of certain proteins Is inserted to a host
recombinant dna
68
insulin and e coli
recombinant dna
69
opium, belladona, ephedrine
plant
70
insulin and thyroid
animal
71
Penicillium notatum (Penicillin)
bacterial and fungal
72
streptomycin and erythromycin
bacteria and fungal
73
KCl and lithium
mineral
74
barbiturates, sulfonamides, ass
synthetic source
75
Crude plant drugs as opium, belladonna, and ephedrine that have been important for centuries
t
76
Accidental discovery of Penicillin gave birth to a large variety of antibiotics Random sampling of higher plants based on anecdotal
t
77
nontraditional or alternative medicinal
nutraceuticals
78
an antiviral agent protects and treats early influenza A • Treats parkinsonian disorders
Amantidine
79
utilizing the cell culture systems with linked enzyme assays and receptor molecules derived from gene cloning
automated high-throughput screening systems
80
Screen enormous libraries of peptides and nucleic acids obtained from procedures
t
81
ADVANCES IN RATIONAL DRUG DESIGN except:
none
82
Usually applied to compounds of known composition using the Chemical Abstract Services (CAS index)
chemical name
83
Substance of plant or animal origin that cannot be classified as pure chemical compounds
biochemical botanical zoological
84
Developed by the manufacturer; selected for their ease of recall but does not give a scientific information about the drug
trademark
85
A single, simple, informative designation available for unrestricted public use. Specific for a given compound even though it may possess a stem common to a related group of drug
generic name or non proprietary
86
Inhibited in a petri dish by the mold Penicillium notatum (Penicillin)
Alexander fleming - 1929
87
Took one step further by injecting Penicillium notatum on a live mice, with controlled experimentation, they found it cured mice with bacterial infections
Florey & chain - 1941
88
Long process () to support that the lead compound is safe and effective before to be tested in human subjects
10 – 15 years
89
Clinical trial would take a decade. Drug discovery usually start with target selection.
t
90
The biological target should be druggable
t
91
CNS diseases must have a drug that can pass throught the blood brain barrier and it is very difficult to develop a drug that can easily penetrate the blood brain barrier. Thus, the target is _.
not druggable
92
Once the biological target is identified, the next thing to do is to determine the lead compound. Lead compounds means has a potential to become a drug.
t
93
lead compound must have a good interaction with the biological target to prove that this compound can interact with the target.
t
94
cell lines, cytotoxicity assays
in vitro
95
rats, any animals
in vivo
96
In vitro – outside living organisms In vivo – conducted on living organisms
t
97
Drug discovery
Target selection < lead discovery < Medicinal Chemistry < In vitro < In vivo < Clinical trials and therapeutics
98
synthesis & Isolation Combinatorial chemistry Assay development High throughput screening
lead discovery
99
Drug affinity & selectivity Cellular disease models MOA Lead candidate refinement
in vitro
100
Animal models of disease states Behavioral studies Functional imaging Ex vivo studies
in vivo